Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-09-16Clinical Trial Update: Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
This clinical trial update notes that the Alzheimer's Disease Neuroimaging Initiative Grand Opportunity study, sponsored by the Alzheimer's …
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Home-Based Assessment for Alzheimer Disease Prevention [NA]
Completed clinical trial assessing home-based assessments for prevention of Alzheimer's disease in individuals with Mild Cognitive Impairmen…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
This clinical trial update discusses factors predictive of a good clinical response to cholinesterase inhibitors in Alzheimer's disease and …
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease [Phase 3]
Phase 3 study evaluating Flutemetamol (18F) injection as a prognostic imaging agent to identify amnestic mild cognitive impairment patients …
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: REVEAL III: Risk Evaluation and Education for Alzheimer's Disease [NA]
Clinical trial update for REVEAL III evaluating risk evaluation and education in Alzheimer's disease; study completed with results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease [Phase 1]
Phase 1 study evaluating single ascending doses of the AAB-001 vaccine in Japanese patients with Alzheimer's disease; the trial is completed…
-
CLINICAL_TRIALS research · 2014-09-03Clinical Trial Update: A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease [NA]
A pilot study investigating the use of transcranial direct current stimulation to treat mild to moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment [NA]
Clinical trial assessing early diagnosis of Alzheimer's disease through clinical, neuropsychological, and neuroimaging follow-up of a cohort…
-
FDA approval · 2014-08-22FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved rivastigmine tartrate as an original ANDA for Macleods Pharmaceuticals Limited, creating a generic version of rivastigmine tart…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center
A completed clinical trial evaluates how well AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, performs in French patie…
-
CLINICAL_TRIALS research · 2014-08-20Clinical Trial Update: Study of STA-1 as an Add-on Treatment to Donepezil [Phase 2]
A Phase 2 clinical trial is evaluating STA-1 as an add-on to donepezil for Alzheimer's disease, sponsored by Sinphar Pharmaceutical Co., Ltd…
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE
The ADVANCE Study evaluating Alzheimer's disease in clinical practice has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Pharmacokinetic Interaction Between AZD3480 and Donepezil [Phase 1]
Phase 1 trial investigating the pharmacokinetic interaction between AZD3480 and donepezil in Alzheimer's disease has been terminated.
-
FDA approval · 2014-08-13FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
The FDA approved a supplemental application for NEURACEQ (florbetaben F-18) submitted by Lantheus Biosciences Ltd.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Escitalopram for the Treatment of Depression in Alzheimer's Disease [Phase 4]
A Phase 4 clinical trial evaluating escitalopram for depressive symptoms in Alzheimer's disease has completed.
-
CLINICAL_TRIALS research · 2014-08-13Clinical Trial Update: Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease [Phase 4]
Phase 4 clinical trial evaluating memantine oral pump for language outcomes in people with probable Alzheimer's disease; the trial's status …
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults [Phase 1]
Phase 1 clinical trial update reporting normative benchmarks for cognitive testing and Alzheimer's disease imaging biomarkers in young adult…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease [Phase 3]
Phase 3 study assessing 24-week efficacy, safety, and tolerability of rivastigmine transdermal patch in probable Alzheimer's disease; study …
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia [Phase 2]
This is a completed Phase 2 trial assessing the safety of E2020 (donepezil) 10 mg, followed by an open-label extension with E2020 SR 23 mg, …
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly [Phase 1]
Phase 1 study evaluating a brain-computer interface-based system for cognitive enhancement in cognitively normal older adults. The trial sta…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Oxaloacetate Pharmacokinetics and Safety [NA]
A completed clinical trial assessing the pharmacokinetics and safety of oxaloacetate in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease [Phase 1]
A Phase 1 clinical trial by Bristol-Myers Squibb evaluating the safety, tolerability, and cerebrospinal fluid biomarker effects of BMS-24102…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease [Phase 2]
Clinical trial update reports the completion of a Phase 2 proof-of-concept study evaluating cognitive improvement in patients with Alzheimer…
-
CLINICAL_TRIALS research · 2014-07-22Clinical Trial Update: Physical Activity Training Program for Patients With Alzheimer's Dementia [NA]
Clinical trial update indicating completion of a study evaluating a physical activity training program for patients with Alzheimer's disease…
-
CLINICAL_TRIALS research · 2014-07-21Clinical Trial Update: Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study. [NA]
Pilot clinical trial evaluating the effect of exercise on cognitive performance in patients with Alzheimer's disease; no results or status d…